| Literature DB >> 36110780 |
Mathi Muthamil Selvi1, Arumugam Selvabalaji2, Anagha Chonat2, Vasanthakumari Ananthan2, Ebenezeer Mani3, Ananda Devi Chinnaswamy4.
Abstract
Background: The goal for placement of intracanal medicament during pulpal therapy procedures is to eradicate the bacteria and the exotoxins from the infected root canal, thereby preventing and controlling pulpal and periradicular infections. Chemo-mechanical preparation is considered an essential step in root canal disinfection; but to accomplish the total elimination of bacteria in highly complex root canal anatomy is difficult. Intracanal medicaments help eliminate bacteria by remaining in the root canal, and calcium hydroxide has been recommended as one of the most effective antimicrobial dressings during endodontic therapy. The herbal agents offer an alternative to synthetic compounds. They have been considered either non-toxic or less toxic. The rapid increase in antibiotic-resistant strains and side effects caused by synthetic drugs have prompted researchers to look for herbal alternatives. Aim and Objective: The in vitro study aims to evaluate and compare the antibacterial activity of triphala and calcium hydroxide against Enterococcus faecalis as an intracanal medicament. Materials andEntities:
Keywords: Calcium hydroxide; enterococcus faecalis; herbal drug; triphala
Year: 2022 PMID: 36110780 PMCID: PMC9469354 DOI: 10.4103/jpbs.jpbs_168_22
Source DB: PubMed Journal: J Pharm Bioallied Sci ISSN: 0975-7406
Figure 1Distribution of samples based on four experimental groups
Comparison of total number of CFUs/ml in triphala-treated groups in different time period of storage in the incubator
| TRIPHALA GROUP | MEAN | S.D. | MINI | MAX |
|
|---|---|---|---|---|---|
| 72 Hours (Group 1) | 41,136.17 | 2,604.65 | 0 | 100,000 | 0.001 (S) |
| 1 Week (Group 3) | 687.2 | 114.5 | 0 | 1,000 | |
| 1 Month (Group 5) | 0 | 0 | 0 |
Comparison of total number of CFUs/ml in calcium hydroxide group in different time period of storage in the incubator using non-parametric Kruskal–Wallis test
| CALCIUM HYDROXIDE GROUP | MEAN | S.D. | MINI | MAX |
|
|---|---|---|---|---|---|
| 72 Hours (Group 2) | 29,784.60 | 4,548.63 | 0 | 100,000 | 0.001 (S) |
| 1 Week (Group 4) | 517.5 | 123.7 | 0 | 1,000 | |
| 1 Month (Group 6) | 0 | 0 | 0 |
Comparison of total number of CFUs/ml when using triphala (group 1) and calcium hydroxide (group 2) in 72 hours of storage in the incubator
| TIME DURATION | DRUG | MEAN | S.D. | MIN | MAX |
|
|---|---|---|---|---|---|---|
| 72 hrs | Triphala (Group 1) | 41,136.17 | 2,604.65 | 0 | 100,000 | 0.001 Significant |
| 72 hrs | Calcium hydroxide (Group 2) | 29,784.50 | 4,548.63 | 0 | 100,000 |
Number of CFU/ml when using triphala (group 3) and calcium hydroxide (group 4) and in one week of storage in the incubator
| TIME DURATION | DRUG | MEAN | S.D. | MINIMUM | MAXIMUM |
|
|---|---|---|---|---|---|---|
| 1 Week | Triphala | 687.2 | 114.5 | 0 | 1000 | Not significant 0.12 |
| 1 Week | Calcium hydroxide | 517.5 | 281.6 | 0 | 1000 |